Redland

[Redland @Cobotical]

@Deepvalue69420 Might be worth a little short position... She has a long way to fall.

[Redland @Cobotical]

@jkafi22873743 Anything you can share?

[Redland @Cobotical]

@DKess1984 @gainzalgo Exactly my thinking. Always hold the core position though so you don't miss out if it keeps going.

[Redland @Cobotical]

@gainzalgo I can't get any AI to give me this list. And the official R3000 additions publication also restricts the list. RVMD I get, the run up from last year April 30th rank day to this year's rank day is astonishing and clearly places it into the ranks of R1000. Not the same with IBRX.

[Redland @Cobotical]

@wliang Can you relook $BRX using your https://t.co/JT7PrWKb46 toolkit please. Is it looking ready to go higher?

[Redland @Cobotical]

@Umbisam This analysis I agree with. Thanks for laying it out. We needed to be in the $9s to get moved up.

[Redland @Cobotical]

@g__j 39362

[Redland @Cobotical]

@SAAS1975 Nice call

[Redland @Cobotical]

@Jagar1496181 @sunxliao Very well indeed. I'm too late to Micron and it was the target Algos so you can never catch bottom. But WYFI was a steal and easy pickings.

Also, price target just revised up to $50!! She's going higher baby.

[Redland @Cobotical]

@Umbisam @IBRXBiz It's going to be an interesting end of session. I can't see it in the R1000 list so You could be right. We'll have to wait to see

[Redland @Cobotical]

@Umbisam @IBRXBiz It's already in R2000, was valued over $2B last review in 2025. R1000 reconstitution threshold is $5.7B. It was over this mark and stayed over since 18th Feb.

[Redland @Cobotical]

@john53835674 @capybaraReborn Whilst short interest is high @ 132M shares, CTB is still low at 3.35%. Even with Fintel data reporting a very low 1000 shares available to lend 15mins ago, thats only 1 broker - until CTB gets ugly we aren't in squeeze territory.

[Redland @Cobotical]

@MaitanMj @DrPatrick Yeah 3 years is 10-50x range. It only takes for Lymphopenia to be recognised as the significant illness it is and Anktiva being the solution and IBRX becomes the most valuable biotech in history.

[Redland @Cobotical]

@k81691558 @alc2022 Most likely floor is $5.98-$6 at the 0.618 Fib level. And even to that it's really struggling to get push down by the shorts through the 0.5fib level.

[Redland @Cobotical]

@MaitanMj @DrPatrick @FDA_KyleD Not just a major Biotech, I see it as the Nvidia of immunotherapy. It's that big of a deal.

Recovering, sustaining and enhancing the immune system IS the future of human longevity.

They have all the elements in progress, along with a few other players to become the defacto.

[Redland @Cobotical]

@theBigY84_ @DrPatrick It's too quiet... This means big news is coming soon.

[Redland @Cobotical]

@Getthere007 @sunxliao It's bottom fell out and shat all over the floor. Luckily I had a stop at my entry.

[Redland @Cobotical]

@sunxliao IBRX please.